Adverse Event Profile for Nanoparticle Albumin-Bound Paclitaxel Compared With Solvent-Based Taxanes in Solid-Organ Tumors: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

BACKGROUND: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) is an innovative form of taxane that has superior antitumor effects; however, the safety profile between nab-paclitaxel and traditional taxanes remains controversial. OBJECTIVE: To determine the burden of adverse events (AEs) in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Fei, Liu, Jiaxuan, Shen, Xin, Wang, Zijing, Li, Qiao, Li, Guohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237853/
https://www.ncbi.nlm.nih.gov/pubmed/34963337
http://dx.doi.org/10.1177/10600280211058385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237853/
https://www.ncbi.nlm.nih.gov/pubmed/34963337
http://dx.doi.org/10.1177/10600280211058385

Ejemplares similares